Ben Matone | Director, IR |
Jacqueline Shea | COO |
Dave Liebowitz | SVP, Clinical Development for Infectious Diseases |
Jeffrey Skolnik | SVP of Clinical Development for Oncology and HPV Therapeutics |
Peter Kies | CFO |
Hartaj Singh | Oppenheimer |
Roger Song | Jefferies |
Yi Chen | H.C. Wainwright & Co. |
Good afternoon, and welcome to the Inovio Pharmaceuticals First Quarter 2022 Financial Results Conference Call. [Operator Instructions]. I would now like to turn the conference over to Ben Matone, Senior Director of Investor Relations. Please go ahead.
Thank you, Operator.